Insiders bet on kidney disease fighter XORTX Therapeutics

INK ResearchFebruary 21, 2021
With the broad market facing some headwinds from US Treasury bond issuance, today INK Research looks at a speculative micro-cap biotech play that will depend more on its ability to deliver innovative kidney disease treatments than on the direction of long bond yields.
Get access to daily trading ideas, trending topics, interviews and more!
Please subscribe to Insider Tracking Advantage Ultra

Other INK Research Videos

INK ResearchMarch 05, 2021
Frontier Lithium insiders are charged up about the future
On March 3rd, Howard Klein made the bullish case for lithium on INK Ultra Money. It did not take long for insiders to lead us to an opportunity in the area. In today's report, INK looks at Frontier Lithium (FL).
INK ResearchMarch 04, 2021
INK Ultra Money Free: Nothing sleepy about Sleep Country stock
Sleep Country Canada (ZZZ) stock has been on a roll since COVID-19 hit. Meanwhile, insider buying shows no signs of taking a rest. Join us today to hear the next insider wake up call on opportunity. Learn more at INKResearc.com or Canadianinsider.com/subscription.
INK ResearchMarch 03, 2021
Nothing sleepy about Sleep Country stock
INK Research starts Thursday with Sleep Country Canada (ZZZ) which has been on a roll since COVID-19 hit. Meanwhile, insider buying shows no signs of taking a rest.

Get an Insider Tracking Advantage Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • and more including access to INK Ultra Money

Only $9.99 per month (plus tax)!